The aim of this study was to evaluate laboratory parameters for investigating their potential predictive ability to differentiate patients with fibromyalgia (FM) from healthy subjects. We carried out a case–control study with 79 FM patients and 20 controls to analyze complete blood count, serum chemistry profile, glycosylated hemoglobin (HbA1c), and erythrocyte sedimentation rate (ESR). The predictive value of these parameters was determined by receiver operating characteristic (ROC) analysis. We also examined the relationships with clinical parameters (functional capacity, pain, and physical and mental health status). Results showed significant differences in red blood cell count, hematocrit, mean corpuscular hemoglobin concentration, platelet count, creatinine, HbA1c, and ESR between groups. According to ROC analysis, all these parameters may assist in making FM diagnosis. Hematocrit and ESR values were correlated with FM clinical parameters. The determination of these routine laboratory parameters may be an uncomplicated means of facilitating FM diagnosis, together with the clinical data of the patient.
AktürkS.BüyükavcıR. (2017). Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia. Clinical Rheumatology, 36, 1885–1889. https://doi.org/10.1007/s10067-017-3647-0
2.
AlonsoJ.PrietoL.AntóJ. M. (1995). [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results]. Medicina Clinica, 104, 771–776.
3.
AlvesB.ZakkaT. M.TeixeiraM. J.KaziyamaH. H.SiqueiraJ. T.SiqueiraS. R. (2016). Depression, sexuality and fibromyalgia syndrome: Clinical findings and correlation to hematological parameters. Arquivos de Neuro-Psiquiatria, 74, 863–868. https://doi.org/10.1590/0004-282X20160141
4.
ArihanO.CaglayanG.BayrakS.AkinciA.FalkmarkenN. D. (2017). Hemorheological parameters in patients with fibromyalgia syndrome. Clinical Hemorheology and Microcirculation, 65, 309–315. https://doi.org/10.3233/CH-16160
5.
BellatoE.MariniE.CastoldiF.BarbasettiN.MatteiL.BonasiaD. E.BlonnaD. (2012). Fibromyalgia syndrome: Etiology, pathogenesis, diagnosis, and treatment. Pain Research and Treatment, 2012, 426130. https://doi.org/10.1155/2012/426130
6.
BrownT. M.GargS.ChandranA. B.McNettM.SilvermanS. L.HadkerN. (2012). The impact of ‘best-practice’ patient care in fibromyalgia on practice economics. Journal of Evaluation in Clinical Practice, 18, 793–798. https://doi.org/10.1111/j.1365-2753.2011.01678.x
7.
Cabo-MeseguerA.Cerdá-OlmedoG.Trillo-MataJ. L. (2017). Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. Medicina Clínica, 149, 441–448. https://doi.org/10.1016/j.medcli.2017.06.008
8.
ColladoA.GomezE.CoscollaR.SunyolR.SoléE.RiveraJ.AltarribaE.CarbonellJ.CastellsX. (2014). Work, family and social environment in patients with fibromyalgia in Spain: An epidemiological study: EPIFFAC study. BMC Health Services Research, 14(1), 513. https://doi.org/10.1186/s12913-014-0513-5
9.
Coskun BenlidayiI. (2019). Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatology International, 39, 781–791. https://doi.org/10.1007/s00296-019-04251-6In Press.
10.
El MaghraouiA.TellalS.AchemlalL.NouijaiA.GhaziM.MounachA.BezzaA.Derouiche ElM. (2006). Bone turnover and hormonal perturbations in patients with fibromyalgia. Clinical and Experimental Rheumatology, 24, 428–431.
11.
ElmasO.YildizS.BilginS.DemirciS.ComlekciS.KoyuncuogluH. R.AkkusS.ColakO. H.ArslanE.OzkanO.BilginG. (2016). Physiological parameters as a tool in the diagnosis of fibromyalgia syndrome in females: A preliminary study. Life Sciences, 145, 51–56. https://doi.org/10.1016/j.lfs.2015.12.029
12.
Erkmen UyarM.SezerS.BalZ.GuliyevO.TutalE.GenctoyG.KulahE.Ozdemir AcarN.HaberalM. (2015). Fibromyalgia and its clinical relevance in renal transplant recipients. Transplantation Proceedings, 47, 1105–1109. https://doi.org/10.1016/j.transproceed.2015.01.026
13.
GerdleB.LarssonB.ForsbergF.GhafouriN.KarlssonL.StenssonN.GhafouriB. (2014). Chronic widespread pain: Increased glutamate and lactate concentrations in the trapezius muscle and plasma. Clinical Journal of Pain, 30, 409–420. https://doi.org/10.1097/AJP.0b013e31829e9d2a
14.
GóesS. M.StefanelloJ. M.HomannD.LodovicoA.Hubley-KozeyC. L.RodackiA. L. (2016). Torque and muscle activation impairment along with insulin resistance are associated with falls in women with fibromyalgia. Journal of Strength and Conditioning Research, 30, 3155–3164.
15.
HaliloğluS.CarliogluA.SahinerE.KaraaslanY.KosarA. (2014). Mean platelet volume in patients with fibromyalgia. Zeitschrift Fur Rheumatologie, 73, 742–745. https://doi.org/10.1007/s00393-013-1330-7
16.
InalS.İnalE. E.OkyayG. U.ÖztürkG. T.ÖneçK.GüzG. (2014). Fibromyalgia and nondipper circadian blood pressure variability. Journal of Clinical Rheumatology, 20, 422–426. https://doi.org/10.1097/RHU.0000000000000189
17.
La RubiaM.RusA.MolinaF.Del MoralM. L. (2013). Is fibromyalgia-related oxidative stress implicated in the decline of physical and mental health status?Clinical and Experimental Rheumatology, 31, S121–S127.
MaffeiM. E. (2020). Fibromyalgia: Recent advances in diagnosis, classification, pharmacotherapy and alternative remedies. International Journal of Molecular Sciences, 21(21), 7877. https://doi.org/10.3390/ijms21217877
21.
MarquesA. P.AssumpçãoA.MatsutaniL. A.PereiraC. A.LageL. (2008). Pain in fibromyalgia and discrimination power of the instruments: Visual analog scale. Dolorimetry and the McGill Pain Questionnaire. Acta Reumatologica Portuguesa, 33(3), 345–351.
22.
MasA. J.CarmonaL.ValverdeM.RibasB.EPISER Study Group. (2008). Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: Results from a nationwide study in Spain. Clinical and Experimental Rheumatology, 26(4), 519–526.
23.
McCullyK. K.NatelsonB. H. (1999). Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clinical Science, 97, 603–608; discussion 611.
MolinaF.del MoralM. L.La RubiaM.BlancoS.CarmonaR.RusA. (2019). Are patients with fibromyalgia in a prothrombotic state?Biological Research for Nursing, 21, 224–230. https://doi.org/10.1177/1099800418824716
26.
Ramírez-TejeroJ. A.Martínez-LaraE.RusA.CamachoM. V.Del MoralM. L.SilesE. (2018). Insight into the biological pathways underlying fibromyalgia by a proteomic approach. Journal of Proteomics, 186, 47–55. https://doi.org/10.1016/j.jprot.2018.07.009
27.
RiveraJ.GonzálezT. (2004). The fibromyalgia impact questionnaire: A validated Spanish version to assess the health status in women with fibromyalgia. Clinical and Experimental Rheumatology, 22, 554–560.
28.
SumptonJ. E.MoulinD. E. (2014). Fibromyalgia. In VinkenP. J.BruynG. W. (Eds.), Handbook of clinical neurology (Vol. 119, pp. 513–527). Elsevier B.V.
29.
TishlerM.SmorodinT.Vazina-AmitM.RamotY.KofflerM.FishelB. (2003). Fibromyalgia in diabetes mellitus. Rheumatology International, 23(4), 171–173.
30.
VilagutG.ValderasJ. M.FerrerM.GarinO.López-GarcíaE.AlonsoJ. (2008). [Interpretation of SF-36 and SF-12 questionnaires in Spain: Physical and mental components]. Medicina Clinica, 130, 726–735.
31.
WolfeF.ClauwD. J.FitzcharlesM. A.GoldenbergD. L.HäuserW.KatzR. L.MeaseP. J.RussellA. S.RussellI. J.WalittB. (2016). 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis and Rheumatism, 46, 319–329. https://doi.org/10.1016/j.semarthrit.2016.08.012
32.
YoudenW. J. (1950). Index for rating diagnostic tests. Cancer, 3, 32–35.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
